Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
06/2013
06/01/2013CA2760174A1 Protein kinase inhibitors and uses thereof
05/2013
05/30/2013WO2013078126A1 Thienopyrimidine inhibitors of atypical protein kinase c
05/30/2013WO2013077345A1 Organic electroluminescent element, and light emitting device, display device and lighting device each using organic electroluminescent element
05/30/2013WO2013077344A1 Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element
05/30/2013WO2013075980A1 Polycyclic aromatic compounds containing an s atom or s(=0)2 group and their use as dyes
05/30/2013WO2013075399A1 Unsaturated 5-membered benzo-heterocyclic compound or pharmaceutical salts thereof, and preparation method, pharmaceutical composition and use thereof
05/30/2013CA2856306A1 Selective kinase inhibitors
05/30/2013CA2856301A1 Pyrazine kinase inhibitors
05/30/2013CA2855446A1 Thienopyrimidine inhibitors of atypical protein kinase c
05/30/2013CA2853252A1 Polycyclic aromatic compounds containing an s atom or s(=0)2 group and their use as dyes
05/29/2013EP2596793A1 Quinoline derivatives as PI3 kinase inhibitors
05/29/2013EP2595993A2 Tricyclic proteasome activity enhancing compounds
05/29/2013EP2595992A1 SEMICONDUCTORS BASED ON SUBSTITUTED [1]BENZOTHIENO[3,2-b][1]-BENZOTHIOPHENES
05/29/2013EP2595987A1 New aminopyrazoloquinazolines
05/29/2013EP2595975A2 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
05/29/2013CN103124732A Novel organic compound and electrochromic device including the same
05/29/2013CN103124723A Novel microbiocides
05/29/2013CN103122006A Fused thiophenes and methods for making and using same
05/29/2013CN101851247B Composition containing clopidogrel bisulfate crystal particles
05/29/2013CN101693714B Spirocyclic cyclohexane derivatives
05/28/2013US8450503 Photochromic and electrochromic compounds and methods of synthesizing and using same
05/28/2013US8450358 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
05/28/2013US8450352 Thiazole compounds and their use for inhibiting phosphodiesterase 4, TNF-α, and IL-4
05/28/2013US8450341 Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors
05/28/2013US8450310 Isoxazole compounds as inhibitors of heat shock proteins
05/28/2013CA2615795C Premature ovulation preventive agent
05/28/2013CA2547887C Protein modifier production inhibitor
05/28/2013CA2530886C Dual nk1/nk3 antagonists for treating schizophrenia
05/23/2013WO2013073896A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/23/2013WO2013072694A1 Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors
05/23/2013WO2013072693A1 Thieno [2, 3 - c] pyrazoles for use as potassium channel inhibitors
05/23/2013WO2012051318A8 Sulphonamide compounds and methods of making and using same
05/23/2013US20130131070 1-Aryl or 1- Heteroaryl-Pyrido(B)indoles and Uses Thereof
05/23/2013US20130131062 Pyridazinones and furan-containing compounds
05/23/2013US20130131050 Fused heterocyclic compound and application thereof
05/23/2013US20130131048 Novel psychotropic agents having glutamate nmda activity
05/23/2013US20130131040 Pyrazine kinase inhibitors
05/23/2013US20130129677 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
05/23/2013CA2855346A1 Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors
05/22/2013EP2594570A1 Crystal of thienopyrimidine derivative
05/22/2013EP2594566A1 Nitrogenated aromatic heterocyclic ring derivative
05/22/2013EP2593457A1 Pyrazolo [1, 5a]pyrimidine and thieno [3, 2b]pyrimidine derivatives as irak4 modulators
05/22/2013CN103119047A Tricyclic proteasome activity enhancing compounds
05/22/2013CN103113387A Synthesis method of asymmetrical dithieno heteroaromatic compounds
05/21/2013US8445680 Tetrahydrothieno pyridines
05/16/2013WO2013069939A1 Compound for organic electronic element, organic electronic element including the same, electronic device thereof
05/16/2013WO2013069771A1 Anthranilic acid derivative and noxious organism control agent
05/16/2013WO2013068470A1 Inhibitors of phosphodiesterase type 10a
05/16/2013US20130123291 Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors
05/16/2013US20130123279 Crystal of thienopyrimidine derivative
05/16/2013US20130123265 Compounds that modulate intracellular calcium
05/16/2013US20130123242 Compounds and methods for the treatment or prevention of flavivirus infections
05/16/2013US20130123241 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
05/16/2013US20130123232 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2013US20130123231 Acc inhibitors and uses thereof
05/16/2013US20130120821 Complimentary polymer electrochromic device
05/16/2013US20130119359 Organic Electroluminescent Element, Material for Organic Electroluminescent Element, and Light Emitting Device, Display Device and Illumination Device Each Using the Element
05/16/2013CA2855372A1 Acc inhibitors and uses thereof
05/16/2013CA2852604A1 Inhibitors of phosphodiesterase type 10a
05/15/2013EP2590986A2 Semiconducting polymers
05/15/2013EP2590984A1 Anellated pyridine compounds
05/15/2013CN103108877A Dithiinopyridazinone derivatives
05/15/2013CN103108875A Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device
05/15/2013CN103108871A 17a-hydroxylase/c17,20-lyase inhibitors
05/15/2013CN103102356A Preparation method of prasugrel hydrobromide
05/15/2013CN103102355A Tetrahydrothienopyridine compound with optical activity
05/15/2013CN103102344A Aminoquinazoline derivative, salts thereof and application method
05/15/2013CN102002054B Pyrazole type compound and preparation method and application thereof
05/14/2013US8440843 2, 2-bipyridine ligand, sensitizing dye and dye sensitized solar cell
05/14/2013US8440825 Fumaric acid salt of varenicline
05/14/2013US8440652 MST1 kinase inhibitors and methods of their use
05/14/2013US8440639 Combination compositions for reducing intraocular pressure
05/14/2013CA2583550C Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
05/10/2013WO2013067277A1 Alkylated piperazine compounds as inhibitors of btk activity
05/10/2013WO2013067274A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity
05/10/2013WO2013067260A1 Bicyclic piperazine compounds
05/10/2013WO2013066732A1 Conjugated fused thiophenes, methods of making conjugated fused thiophenes, and uses thereof
05/10/2013WO2013066067A1 Phenol monomer, polymer for forming a resist underlayer film including same, and composition for a resist underlayer film including same
05/10/2013WO2013064083A1 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
05/10/2013WO2013064068A1 Thienopyrimidine and furopyrimidine derivatives, preparation method thereof and medical use thereof
05/10/2013WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
05/10/2013CA2853975A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity
05/10/2013CA2853970A1 Alkylated piperazine compounds as inhibitors of btk activity
05/10/2013CA2852964A1 Bicyclic piperazine compounds
05/09/2013US20130116447 Fused polyheteroaromatic compound, organic thin film including the compound, and electronic device including the organic thin film
05/09/2013US20130116262 Bicyclic piperazine compounds
05/09/2013US20130116245 Alkylated piperazine compounds
05/09/2013US20130116241 Novel inhibitor compounds of phosphodiesterase type 10a
05/09/2013US20130116235 Heteroaryl pyridone and aza-pyridone compounds
05/09/2013US20130116233 Novel inhibitor compounds of phosphodiesterase type 10a
05/09/2013US20130116230 3-aminopyrrolidine derivatives as modulators of chemokine receptors
05/09/2013US20130116213 Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity
05/09/2013US20130112946 Novel heterocyclic compound and organic light-emitting device including the same
05/08/2013EP2588484A1 Novel organic compound and electrochromic device including the same
05/08/2013EP2588483A1 Improved process for preparing a pharmaceutical compound
05/08/2013EP2588451A1 Piperidine derivatives and their use for the treatment of metabolic disorders
05/08/2013CN103098253A Organic electroluminescent element
05/08/2013CN103097388A New aminopyrazoloquinazolines
05/08/2013CN103087078A Thienopyridine and furopyridine kinase inhibitors
05/08/2013CN103087077A Thienopyrimidine and furopyrimidine derivative, its preparation method and application in medicines
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 214